Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

KIOmed Pharma

KIOmed Pharma
2012 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Grant LATEST DEAL TYPE
$77.2K LATEST DEAL AMOUNT
7 INVESTORS
Description

Provider of therapeutic devices designed to treat patients who suffer from high impact pathologies. The company's devices and implants integrate proprietary animal-free chitosan-based technologies in the field of ophthalmology, hemostasis, biosurgery, tissue engineering and regenerative medicine, enabling healthcare providers to cure their patients.

Formerly Known As
Synolyne Pharma
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Primary Office
  • Rue Haute Claire, 4
  • 4040 Herstal
  • Belgium

+32 04 000 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore KIOmed Pharma’s full profile, request a free trial.

KIOmed Pharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 21-Dec-2016 $77.2K 000.00 Completed Generating Revenue
3. Early Stage VC 17-Jun-2016 00.00 000.00 Completed Generating Revenue
2. Early Stage VC 07-Jun-2014 $4.58M $4.58M 00.00 Completed Generating Revenue
1. Accelerator/Incubator 01-Nov-2012 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

KIOmed Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Class B 0,000 0000.00 0000.00 00 0000.00 00.000
Class A 00,000 0000.00 0000.00 00 0000.00 00.000
Class B 4,800 $136.67 $136.67 1x $136.67 9.08%
Class A 4,200 $136.67 $136.67 1x $136.67 9.08%
To view this company’s complete Cap Table, request access »

KIOmed Pharma Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000000 01-Jan-2014 000000 00 000000 Food Products
To view this company’s complete investment and acquisition history, request access »

KIOmed Pharma Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
European Union Government 000 0000 000000 0
Portail de la Wallonie Other 000 0000 000000 0
Flexximum R&D Other Minority 000 0000 000000 0
KitoZyme Corporation Minority 000 0000 000000 0
Noshaq Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »

KIOmed Pharma Executive Team (5)

Name Title Board
Seat
Contact
Info
Houtai Choumane Ph.D Chief Executive Officer, Managing Director and Board Member
Pierre Douette Ph.D Chief Operating Officer
Sandrine Gautier Ph.D Value Stream Director
François Blondel Co-Founder & Chairman
Yves Henrotin Ph.D Co-Founder, Vice Chairman and Chairman of the Scientific Board

KIOmed Pharma Board Members (5)

Name Representing Role Since Contact
Info
François Blondel Self Co-Founder & Chairman 000 0000
Francoise Leblanc Noshaq Board Member 000 0000
Géry Lefebvre KIOmed Pharma Board Member 000 0000
Marc Nolet de Brauwere Self Board Member 000 0000
Yves Henrotin Ph.D Self Co-Founder, Vice Chairman and Chairman of the Scientific Board 000 0000